Raymond James Financial’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.5M Sell
1,164,639
-87,021
-7% -$7.02M 0.03% 576
2026
Q1
$88.4M Sell
1,251,660
-167,790
-12% -$12.6M 0.03% 562
2025
Q4
$112M Sell
1,419,450
-11,468
-0.8% -$908K 0.03% 457
2025
Q3
$118M Buy
1,430,918
+10,701
+0.8% +$842K 0.04% 446
2025
Q2
$114M Buy
1,420,217
+47,980
+3% +$3.7M 0.04% 434
2025
Q1
$110M Buy
1,372,237
+108,225
+9% +$9M 0.04% 398
2024
Q4
$103M Buy
+1,264,012
New +$105M 0.04% 425

Other funds holding MET

Raymond James Financial's MET Position: Q2 2026 in Review

Raymond James Financial reduced its MetLife (MET) stake by 7% in Q2 2026, selling an estimated $7.02M and leaving 1,164,639 shares worth $98.5M. The position accounts for 0.03% of the portfolio, ranked #576.

Raymond James Financial first reported a position in MET in Q4 2024 and has held it in 7 quarters since. The position peaked at $118M in Q3 2025. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Raymond James Financial held 1,164,639 shares of MetLife worth $98.5M as of Q2 2026.
  • Raymond James Financial sold 87,021 MetLife shares in Q2 2026, an estimated $7.02M.
  • MetLife made up 0.03% of Raymond James Financial's portfolio in Q2 2026, its #576 holding.
  • Raymond James Financial first reported a position in MetLife in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's MetLife position peaked at $118M in Q3 2025.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.